Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
23
# OF OVERLAPPING
HOLDINGS
XBI
116
HOLDINGS
20%
ALSO IN PBE
PBE
27
HOLDINGS
85%
ALSO IN XBI
SECTOR DRIFT (XBI minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.5% | 7.4% | 3.5% |
|
HALOZYME THERAPEUTICS INC | 3.1% | 3.2% | 3.1% |
|
INCYTE CORP | 2.8% | 3.5% | 2.8% |
|
UNITED THERAPEUTICS CORP | 2.6% | 4.7% | 2.6% |
|
NEUROCRINE BIOSCIENCES INC | 2.5% | 2.8% | 2.5% |
XBI Overweight Relative to PBE
|
INSMED INC | 3.1% |
|
REGENERON PHARMACEUTICALS | 2.6% |
|
ABBVIE INC | 2.5% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.4% |
|
BIOGEN IDEC INC | 2.4% |
|
BRIDGEBIO PHARMA, INC. | 2.3% |
|
NATERA INC | 2.3% |
|
MODERNA, INC. | 2.2% |
 |
ROIVANT SCIENCES LTD. | 1.7% |
|
CYTOKINETICS INC | 1.6% |
XBI Underweight Relative to PBE
|
ILLUMINA INC | -5.8% |
|
ROYALTY PHARMA PLC CLASS A | -5.3% |
|
ALNYLAM PHARMACEUTICALS INC | -3.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.3% |
|
ANAVEX LIFE SCIENCES CORP. | -3.3% |
|
GILEAD SCIENCES INC | -2.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -2.7% |
|
AMGEN INC | -2.7% |
|
REPLIGEN CORP | -2.6% |
|
DYNAVAX TECHNOLOGIES CORP | -2.5% |